(Q93911529)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9723424%20AND%20SRC:MED&resulttype=core&format=json

11 May 2020

title

Daclizumab: outcome of phase III trials and mechanism of action. Double Therapy and the Triple Therapy Study Groups (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9723424%20AND%20SRC:MED&resulttype=core&format=json

11 May 2020

main subject

phase III clinical trial

1 reference

F Vincenti

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9723424%20AND%20SRC:MED&resulttype=core&format=json

11 May 2020

B Nashan

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9723424%20AND%20SRC:MED&resulttype=core&format=json

11 May 2020

S Light

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9723424%20AND%20SRC:MED&resulttype=core&format=json

11 May 2020

publication date

1 August 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9723424%20AND%20SRC:MED&resulttype=core&format=json

Transplantation Proceedings

11 May 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9723424%20AND%20SRC:MED&resulttype=core&format=json

11 May 2020

volume

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9723424%20AND%20SRC:MED&resulttype=core&format=json

11 May 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9723424%20AND%20SRC:MED&resulttype=core&format=json

11 May 2020

page(s)

2155-2158

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9723424%20AND%20SRC:MED&resulttype=core&format=json

Randomized controlled trial of a monoclonal antibody against the interleukin-2 receptor (33B3.1) as compared with rabbit antithymocyte globulin for prophylaxis against rejection of renal allografts

11 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2900571-5

7 January 2021

A randomized prospective trial of anti-Tac monoclonal antibody in human renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2900571-5

7 January 2021

A double-blind, placebo-controlled study of monoclonal anti-interleukin-2 receptor antibody (BT563) administration to prevent acute rejection after kidney transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2900571-5

7 January 2021

A phase I trial of humanized anti-interleukin 2 receptor antibody in renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2900571-5

7 January 2021

10.1016/S0041-1345(98)00571-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9723424%20AND%20SRC:MED&resulttype=core&format=json

11 May 2020

1 reference